Dr. Reddy's Laboratories Limited
DRREDDY · NSE · Pharmaceuticals · Generics · US listing: RDY
About the company
Dr. Reddy's Laboratories is one of India's largest pharmaceutical companies, manufacturing and marketing generic drugs, active pharmaceutical ingredients, and biosimilars across more than 80 countries. The company has a strong presence in the US generics market and maintains a dual listing in India and the United States. It was one of the first Indian pharmaceutical companies to list on the New York Stock Exchange.
| Exchange | NSE |
| Ticker | DRREDDY |
| Sector | Pharmaceuticals · Generics |
| US listing | RDY |
| Indicative market cap USD | $12.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
Trades in the US as RDY, available through most US brokerage accounts.
On its home market (NSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — official exchange listing
Availability information only. Not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in India
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only. Not investment advice. Verify with the exchange, the company's filings and your broker.